TITLE

ADENOMATOUS POLYPS ARE RARE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

AUTHOR(S)
Dixon, A.; Wurm, P.; Robinson, R.; Hart, A.
PUB. DATE
April 2003
SOURCE
Gut;Apr2003 Supplement 1, Vol. 52, pA65
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Objective: The prevalence of adenomatous colorectal polyps in inflammatory bowel disease (IBD) is unknown, although recent reports suggest they might be rare in patients with ulcerative colitis (UC). Previous work has suggested 5-ASA compounds may protect against colorectal cancer. The aim of this study was to compare the prevalence of left sided adenomas in patients with IBD with a local age matched control population. Method: We reviewed the medical notes of 106 patients with histologically proven IBD, aged 55-64 years at the time of endoscopy for the presence of left sided colonic adenomas. Patients were identified through our endoscopy/histology databases. The prevalence of adenomas was compared with a healthy control population in Leicestershire aged 55-64 years who participated in a screening programme for colorectal cancer with flexible sigmoidoscopy. Results: Of 106 patients (61 male, 45 female, mean age 59 years), 80 suffered from UC, 20 from Crohn's disease and 6 from indeterminate colitis. All patients had undergone at least a flexible sigmoidoscopy and 75 had a colonoscopy. Adenomas were found in 3 patients with ulcerative colitis compared to 67 of 749 controls (2.8% v 8.9%, chi² =4.6, p=0.03). Of the 3 patients that had polyps, one patient with a 15 year history of UC had a 8mm rectal tubular adenoma, a second patient had a 4 year history of proctitis had a 2mm rectal adenoma and the third patient had, at diagnosis, a 2 cm tubulovilious odenoma. Dysplasia associated with colitis was seen in a further 4 (3.2%) patients. Pseudopolyps were found in 6 (5.6%) patients and metaplastic polyps in 2 (1.8%) patients. 75 (71%) of the IBD patients were maintained on a 5-ASA compound. Conclusions: The results suggest that adenomatous polyps are rare in patients aged 55-64 years with IBD compared to a control population. This supports the hypothesis that lesions other than polyps are important for the development of colorectal cancer in patients with LBD...
ACCESSION #
9747731

 

Related Articles

  • PSEUDOPOLYPOSIS AND THE CANCER PROBLEM IN ULCERATIVE COLITIS. Kanin, Harry J. // American Journal of Gastroenterology;May1965, Vol. 43 Issue 5, p484 

    Discusses pseudopolyposis and the cancer problem in ulcerative colitis. Clinical features of pseudopolyposis; Incidence of carcinoma in patients with ulcerative colitis; Factors involved in the development of colon cancer in patients with ulcerative colitis.

  • The management of dysplasia associated with ulcerative colitis: colectomy versus continued surveillance. Friedlich, Martin S.; Guindi, Maha; Stern, Hartley S. // Canadian Journal of Surgery;Jun2004, Vol. 47 Issue 3, p212 

    The article focuses on the management of dysplasia associated with ulcerative colitis (UC). Colectomy versus continued surveillance in patients with longstanding UC is a challenging decision. Several factors must be considered. Often such patients have quiescent disease, making the prospect of...

  • Cytokines: From Gut Inflammation to Colorectal Cancer. Fantini, Massimo C.; Pallone, Francesco // Current Drug Targets;May2008, Vol. 9 Issue 5, p375 

    Colorectal cancer represents a life-threatening complication of inflammatory bowel diseases. Statistics indicate that the risk to develop colorectal cancer is higher in patients affected by ulcerative colitis and to a lesser extent by Crohn's disease and that such a risk is directly proportional...

  • Immune responses triggering colitis and colitis-associated carcinoma. Kesselring, Rebecca; Fichtner-Feigl, Stefan // Langenbeck's Archives of Surgery;Apr2012, Vol. 397 Issue 4, p527 

    Inflammatory bowel diseases compromise of two forms of chronic intestinal inflammatory disorders: Crohn's disease and ulcerative colitis. Both forms of inflammatory bowel disease result from inappropriate inflammatory responses to the intestinal microbiota, but have different underlying immune...

  • Disease activity and cancer risk in inflammatory bowel disease associated with primary sclerosing cholangitis. Sokol, Harry; Cosnes, Jacques; Chazouilleres, Olivier; Beaugerie, Laurent; Tiret, Emmanuel; Poupon, Raoul; Seksik, Philippe; Ukleja, Andrew // World Journal of Gastroenterology;6/14/2008, Vol. 14 Issue 22, p3497 

    AIM: To investigate the phenotype of inflammatory bowel disease associated with primary sclerosing cholangitis (PSC-IBD). METHODS: Data from 75 PSC-IBD patients evaluated in our tertiary center between 1963 and 2006 were collected and compared to 150 IBD patients without PSC, matched for sex,...

  • Expression of apoptosis related proteins during malignant progression in chronic ulcerative colitis. van der Woude, C. J.; Moshage, H.; Homan, M.; Kleibeuker, J. H.; Jansen, P. L. M.; van Dekken, H. // Journal of Clinical Pathology;Aug2005, Vol. 58 Issue 8, p811 

    Background: Chronic ulcerative colitis (CUC) is associated with increased risk of developing colon cancer through a dysplasia (intraepithelial neoplasia)-carcinoma sequence. Aims: To investigate the expression of apoptosis and inflammatory related proteins in CUC. Methods: The expression of...

  • Thiopurines prevent advanced colorectal neoplasia in patients with inflammatory bowel disease. Fiona D M van Schaik // Gut;Feb2012, Vol. 61 Issue 2, p235 

    BACKGROUND AND AIMS: Previous studies have suggested a chemopreventive effect of 5-aminosalicylic acid (5-ASA) therapy in patients with inflammatory bowel disease (IBD). This effect has not been reported in IBD patients using thiopurines. We investigated the association between thiopurine or...

  • Signaling Molecules: The Pathogenic Role of the IL-6/STAT-3 Trans Signaling Pathway in Intestinal Inflammation and in Colonic Cancer. Atreya, R.; Neurath, M. F. // Current Drug Targets;May2008, Vol. 9 Issue 5, p369 

    Although the precise etiology of inflammatory bowel diseases (IBD) still remains unclear, considerable progress has been made in the identification of novel signal transduction pathways that elucidate the immunopathogenesis involved in the perpetuation of the inflammatory process. As both...

  • MALIGNANT DEGENERATION IN CHRONIC INFLAMMATORY DISEASE OF THE COLON AND SMALL INTESTINE. Weingarten, Berthold; Weiss, Jerome // American Journal of Gastroenterology;Feb1960, Vol. 33 Issue 2, p203 

    Presents cases of adenocarcinoma occurring in instances of long-standing, chronic granulomatous enteritis. Overview of reports on malignant degeneration and cancer of the colon; Cause of malignant degeneration in ulcerative colitis; Literature on inflammatory disease of the small bowel,...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics